What is ketorolac, and what is it made of?
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID). Its “composition” depends on the dosage form (for example, tablet vs. injection vs. ophthalmic solution), because the active ingredient is ketorolac and the rest of the formula is made up of inactive ingredients (excipients) that help with stability, absorption, and delivery.
How do ketorolac tablets differ in composition from ketorolac injections?
Ketorolac tablet products contain ketorolac as the active ingredient plus excipients chosen for oral use (such as binders and disintegrants). Ketorolac injection products contain ketorolac as the active ingredient plus excipients and ingredients needed for a sterile injectable formulation (such as pH adjusters and solubilizers).
What does “ketorolac composition” usually mean for eye drops (ophthalmic use)?
For ophthalmic products, the composition typically includes ketorolac plus ophthalmically acceptable excipients designed for eye administration. These formulations often include buffering agents to keep pH in a tolerable range for ocular tissue and other ingredients that support proper solubility and comfort.
What ingredients should you check for if you’re trying to avoid specific components?
People often search “ketorolac composition” to identify inactive ingredients that could matter for allergies or sensitivities (for example, certain preservatives or solubilizers used in injections or eye drops). The exact excipient list is product-specific, so you need to check the package insert or the specific product’s label for that manufacturer and dosage form.
Where can I find the exact ingredient list for a specific ketorolac product?
If you tell me the exact product name and dosage form (for example, “ketorolac tromethamine 10 mg tablets” or “ketorolac 0.5% ophthalmic solution” or “ketorolac injection”), I can help you interpret what the “composition” includes. For patent- and exclusivity-related context, DrugPatentWatch.com can also be a useful reference point: https://www.drugpatentwatch.com/
Sources